What smart money is saying about Prestige Consumer Healthcare Inc.
PBH
No fund has written a full thesis on Prestige Consumer Healthcare Inc. in our archive, but 4 fund letters report a position in it — most recently Ariel Investments Small Cap Value Strategy in June 2026.
Get an email when a fund writes about it
4
Reported positions
0
Bought
0
Sold
4
Letters
Position history
Every position in Prestige Consumer Healthcare Inc. on record in the archive was reported in Q2 2026, across 4 fund letters, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 4 | 0 | 0 | 0 |
Fund activity · 4 positions
- June 2026
Listed in Ariel Investments Small Cap Value Strategy’s reported holdings.
Prestige Consumer Healthcare Inc. - June 2026
“In pharmaceuticals, Prestige Consumer Healthcare underperformed due to ongoing disruptions in its Clear Eyes product line, stemming from a slower-than-expected recovery in manufacturing operations at a facility.”
Prestige Consumer Healthcare Inc. - June 2026
“Selected health care holdings also declined, specifically Prestige Consumer Health and blood plasma business Grifols.”
Prestige Consumer Healthcare Inc. - June 2026
“Shares of Prestige Consumer Healthcare (PBH) moved lower following disappointing earnings, driven primarily by ongoing supply constraints in its eye care segment and extended lead times in the Middle East.”
Prestige Consumer Healthcare Inc.
Read the letters behind these Prestige Consumer Healthcare Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger